Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

Results of research that identified new causes of Atherosclerotic Coronary Artery Disease, or ASCAD, have been reported by G3 Therapeutics (Global Genomics Group) and Aitia.

News | Cardiac Diagnostics

Research Identifies Potential New Biomarkers of Atherosclerotic Coronary Artery Disease

February 8, 2023 — Results of research that identified new causes of Atherosclerotic Coronary Artery Disease, or ASCAD ...

February 08, 2023

University of Virginia researchers and their collaborators have identified genes that play key roles in the development of coronary artery disease

News | Structural Heart

Genes Responsible for Coronary Artery Disease, World’s No. 1 Killer, Identified

February 6, 2023 — University of Virginia researchers and their collaborators have identified genes that play key roles ...

February 06, 2023

News | Atrial Fibrillation

The Best Genetic Predictors of Heart Arrhythmia and Hidden Comorbidity

February 6, 2023 — In the largest genetic study of heart arrhythmia to date, researchers led by Kazuo Miyazawa and Kaoru ...

February 06, 2023

Using stroke as a measure of quality after TAVR could put stroke centers at a disadvantage, the study suggests

News | Stroke

Hospitals Without Highest Stroke Care Designation May Miss Them After Heart Procedure

February 1, 2023 — A Michigan Medicine study suggests that hospitals without the highest stroke care designation may be ...

February 01, 2023

Imricor, a global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation products, is pleased to announce that it has entered into a Memorandum of Understanding (MOU) with GE HealthCare.

News

Imricor Collaborates with GE HealthCare in Interventional Cardiac MRI

January 31, 2023 —Imricor, a global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation ...

January 31, 2023

This image shows the mitral valve of the heart of a mouse that lacks the serotonin transporter (SERT) gene. The valve was stained with prico-sirius red to show collagen. SERT knockout mice had a thickened mitral valve compared to normal mice. Image courtesy of Columbia University Irving Medical Center

News | Cardiovascular Surgery

Columbia Researchers Find Link Between Serotonin and Heart Valve Disease

January 31, 2023 — Serotonin can impact the mitral valve of the heart and potentially accelerate a cardiac condition ...

January 31, 2023

News | Cardiovascular Clinical Studies

Study extends understanding of blood cell mutations as cardiovascular risk factor

January 26, 2023 — A newly-released study extends the understanding of how acquired mutations in blood cells act as a ...

January 26, 2023

News | Cardiovascular Clinical Studies

Joint Statement on Revised Randomized Clinical Trial Guidelines Issued by ESC, WHF, AHA and ACC

January 24, 2023 — Four cardiology organizations have joined forces in a call to action to reinvent randomized clinical ...

January 24, 2023

UCSF-ZSFG Study Suggests ‘Non-Traditional’ Factors Drive Higher Rates

News | Stroke

Do Sexual Orientation and Gender Identity Affect Stroke Risk?

January 20, 2023 — People who identify as lesbian, gay, bisexual, transgender or non-binary may have a higher risk for s ...

January 20, 2023

Phone calls from a nurse may improve survival for patients treated for heart failure, according to a new study by investigators from the Smidt Heart Institute at Cedars-Sinai.

News | Heart Failure

Calling Patients After Heart Failure May Save Lives

January 18, 2023 — Phone calls from a nurse may improve survival for patients treated for heart failure, according to a ...

January 18, 2023

RUDN doctors analyzed the latest research on the use of RNA for the treatment and diagnosis of ischemic stroke. And, although it is too early to talk about clinical use, one of the RNAs turned out to be both a promising biomarker and a therapeutic target

News | Stroke

RNA Will Help Treat and Diagnose Ischemic Stroke

January 17, 2023 — Ischemic stroke, or cerebral infarction, ranks first in prevalence among diseases that lead to death ...

January 17, 2023

ADVANCE Trial compares sac regression in the Medtronic Endurant II/IIs stent graft system and the Gore® Excluder AAA Device Family systems

News | Stent Grafts

Medtronic Announces First Enrollment in Head-to-head Global Randomized Trial Evaluating Durability of Endovascular Aneurysm Repair

January 12, 2023 — Medtronic announced the first patient enrollment in the ADVANCE Trial, a head-to-head randomized ...

January 12, 2023

Phase 2 trials underway with ninerafaxstat in three cardiovascular indications; multiple data read-outs expected in 2023

News | Cardiovascular Clinical Studies

Imbria Enrolls First Patient in the Phase 2 IMPROVE-DiCE Clinical Trial Evaluating Ninerafaxstat in Patients with Heart Failure with Preserved Ejection Fraction

January 11, 2023 — Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company developing novel therapies ...

January 11, 2023

$TGCV is an emerging cardiovascular disorder characterized by diffuse narrowing coronary atherosclerosis with triglyceride (TG) deposition caused by defective intracellular lipolysis. TGCV is an often-undiagnosed condition in patients who are resistant to standard therapies. Panels A and B concern two patients in their 60s with refractory angina pectoris and diabetes mellitus. After being diagnosed with TGCV, they started dietary intake of tricaprin. Their symptoms improved within a couple of months. Follow-$

News | Heart Failure

A Dietary Supplement Leads to Remarkable Regression in Atherosclerotic Lesions

January 9, 2023 — When we were little, our parents told us to take our vitamins so we could grow big and strong. Now ...

January 09, 2023

Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced the acceptance of the AcQForce Flutter abstract titled “AcQForce Flutter Trial Clinical Results: Force Sensing RF Ablation with Low Flow Gold Tip Catheter for Typical Flutter”

News | Cardiovascular Clinical Studies

Acutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation at the 2023 AF Symposium

January 3, 2023 — Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac ...

January 03, 2023